Global Excellence in Integrative Oncology: ICIM Rome 2023
Scientific Partnership with Prof. Dr. Giammaria Fiorentini
The Imunomedica team (Dr. Virgiliu Vlaescu George, Cristian Gologan M.Sc., Dr. Veronica Iatan, Dr. Laurentiu Broscaru) participated in the 2nd World Congress of Integrative Medicine, consolidating oncological hyperthermia protocols at the highest global level.
Certification of hyperthermia clinical expertise – Cristian Gologan M.Sc.
ICIM Rome Plenary Session – The future of integrative oncological medicine.
Global Scientific Leadership
Prof. Dr. Giammaria Fiorentini is a prolific member of the ESHO (European Society for Hyperthermic Oncology) and an active member of the Scientific Advisory Board (SAB) for SRHO and SIIO. Our direct collaboration ensures patients access to clinical outcomes validated by over 350 published papers.
Mechanism of Action Documented in Prof. Fiorentini’s Research
13.56 MHz
Selectivity: Radio waves detect malignant cells due to their high electrical conductivity.
Thermal Stress
Apoptosis: Targeted heat induces cancer cell destruction without affecting healthy tissue.
️ Immunity
Abscopal Effect: Priming the immune system to recognize and attack systemic malignant cells.
Major Clinical References: Prof. Giammaria Fiorentini
[2023] Hyperthermia combined with chemotherapy vs chemotherapy in patients with advanced pancreatic cancer.
A multicenter comparative study demonstrating an increase in median survival from 9 to 20 months through mHT integration.
Author: Fiorentini G, et al. | World J Clin Oncol. PMID: 37398545
[2021] Modulated electro-hyperthermia in stage III and IV pancreatic cancer: Results on 158 patients.
Observational analysis on one of the largest patient cohorts, confirming tumor control in advanced stages.
Author: Fiorentini G, et al. | World J Clin Oncol. PMID: 34909400
[2019] mHT in Integrative Cancer Treatment for Relapsed Malignant Glioblastoma and Astrocytoma.
Controlled multicenter study on patients with brain recurrences, validating safety and life extension.
Author: Fiorentini G, et al. | Integr Cancer Ther. PMID: 30580645
[2020] Quo Vadis Oncological Hyperthermia?
Seminal review redefining oncological hyperthermia, emphasizing nanoscopic selectivity of malignant cells.
Co-author: Fiorentini G | Front Oncol. PMID: 33014841
Explore Prof. Fiorentini’s full research portfolio: